These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22200437)

  • 21. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure.
    Kalantar-Zadeh K; Mehrotra R; Fouque D; Kopple JD
    Semin Dial; 2004; 17(6):455-65. PubMed ID: 15660576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of ghrelin and ghrelin analogues in wasting disease.
    Kamiji MM; Inui A
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):443-51. PubMed ID: 18542005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease.
    Feldt-Rasmussen B; El Nahas M
    Semin Nephrol; 2009 Jan; 29(1):50-8. PubMed ID: 19121474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships between vascular resistance and energy deficiency, nutritional status and oxidative stress in oestrogen deficient physically active women.
    O'Donnell E; Harvey PJ; De Souza MJ
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):294-302. PubMed ID: 18616718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis.
    Pérez-Fontán M; Cordido F; Rodríguez-Carmona A; Peteiro J; García-Naveiro R; García-Buela J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2095-100. PubMed ID: 15187192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantation.
    Arbeiter AK; Büscher R; Petersenn S; Hauffa BP; Mann K; Hoyer PF
    Nephrol Dial Transplant; 2009 Feb; 24(2):643-6. PubMed ID: 18809976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic acidosis stimulates protein metabolism in uremia.
    Mitch WE
    Miner Electrolyte Metab; 1996; 22(1-3):62-5. PubMed ID: 8676827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress in uremia: the role of anemia correction.
    Lahera V; Goicoechea M; de Vinuesa SG; Oubiña P; Cachofeiro V; Gómez-Campderá F; Amann R; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S174-7. PubMed ID: 17130258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ghrelin in the regulation of body weight and metabolism.
    Castañeda TR; Tong J; Datta R; Culler M; Tschöp MH
    Front Neuroendocrinol; 2010 Jan; 31(1):44-60. PubMed ID: 19896496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle.
    Barazzoni R; Bosutti A; Stebel M; Cattin MR; Roder E; Visintin L; Cattin L; Biolo G; Zanetti M; Guarnieri G
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E228-35. PubMed ID: 15328073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translational research of ghrelin.
    Ueno H; Shiiya T; Nakazato M
    Ann N Y Acad Sci; 2010 Jul; 1200():120-7. PubMed ID: 20633140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease.
    Garibotto G; Sofia A; Saffioti S; Bonanni A; Mannucci I; Verzola D
    Clin Nutr; 2010 Aug; 29(4):424-33. PubMed ID: 20207454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid hormone action in chronic kidney disease.
    Amato AA; Santos GM; Neves Fde A
    Curr Opin Endocrinol Diabetes Obes; 2008 Oct; 15(5):459-65. PubMed ID: 18769220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
    Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
    J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of pro-inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients.
    Witasp A; Carrero JJ; Heimbürger O; Lindholm B; Hammarqvist F; Stenvinkel P; Nordfors L
    J Intern Med; 2011 Apr; 269(4):410-9. PubMed ID: 21054584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of protein kinetics in chronic renal failure.
    Guarnieri G; Toigo G; Situlin R; Ciocchi B; Biolo G
    Miner Electrolyte Metab; 1997; 23(3-6):214-7. PubMed ID: 9387120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac, skeletal, and smooth muscle regulation by ghrelin.
    Leite-Moreira AF; Rocha-Sousa A; Henriques-Coelho T
    Vitam Horm; 2008; 77():207-38. PubMed ID: 17983858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic effects of ghrelin and its potential implications in uremia.
    Barazzoni R; Zanetti M; Biolo G; Guarnieri G
    J Ren Nutr; 2005 Jan; 15(1):111-5. PubMed ID: 15648018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms for protein catabolism in uremia: metabolic acidosis and activation of proteolytic pathways.
    Greiber S; Mitch WE
    Miner Electrolyte Metab; 1992; 18(2-5):233-6. PubMed ID: 1465065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy.
    Himmelfarb J
    Semin Dial; 2009; 22(6):636-43. PubMed ID: 20017834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.